Journal of Clinical Pathology · 1987 · 58 citations · 21 references
MedicineOncologyPathologyBreast OncologyMetastasisSurvival AnalysisBreast Cancer RecurrenceBreast PathologyCancer DiagnosisCancer StagingCancer Survival AnalysisPrognostic AssessmentBreast Cancer PrognosisEstrogen Receptor StatusLymph Node Involvement PrognosisLymph Node MetastasesLymph Node Metastasis PrognosisPathology ReportsPrognostic Factors AnalysisPrognostic Variables
In a prospective study the predictive value of a multivariate morphometric prognostic index was evaluated in 195 patients with primary breast cancer who had not been treated with any form of chemotherapy or hormonal treatment. The presence or absence of distant tumour recurrence combined with the scores of the prognostic index were compared with the survival curves predicted in a previous study. The value of the presence of lymph node metastases, number of positive nodes, tumour size, mitotic activity index, and oestrogen receptor status in prediction of prognosis were also investigated. In agreement with the results of the previous retrospective study, the prospective use of the index had the strongest predictive prognostic value, followed by the mitotic activity index. Statistical analysis showed that the actual prognoses of 43 of the 195 patients (22%) were more accurately determined by the prognostic index rather than by using the presence of the lymph node metastases as the classifying variable. The prognostic index is consistently reproducible by different technicians; it is a reliable method of predicting distant recurrence of tumour and hence the prognosis of patients with primary breast carcinoma. It provides more prognostic information than the presence of lymph node metastases alone, and the index should be incorporated in routine pathology reports.
21
WHO Handbook for Reporting Results of Cancer Treatment
M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text
Medicine, Oncology, Cancer Control +11
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
William A. Knight, Robert B. Livingston, E Gregory et al. · PubMed · 1977 · 706 citations
Medicine, Endocrinology, Oncology +16
Takuma Nemoto, J Vána, Ramez Bedwani et al. · Cancer · 1980 · 669 citations